Summit Therapeutics (SMMT) stock falls as the company faces uncertainty in winning U,S, nod for lead drug after mixed data ...

The findings suggest assessment of CD20 may be an important factor in determining treatment options in B-cell lymphomas.

Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs, announces that ...

The FDA Oncologic Drug Advisory Committee meetings on Tuesday and Wednesday discussed therapies across lymphoma, multiple myeloma, bladder cancer, and prostate cancer.